# Vision - Cancer Clinical AI Evaluation Platform

## Vision Statement
The Cancer Clinical AI Evaluation Platform is a production-grade MLOps system built specifically for clinical environments. Its vision is to establish a rigorous, automated verification gate for Large Language Models (LLMs) deployed within oncology contexts. By validating accuracy, faithfulness, safety, and source grounding, the platform ensures that doctors, nurses, and researchers retrieve oncology information without risking exposure to hallucinated or medically unsafe recommendations.

## Platform Objectives
- **Safety Gating**: Block any candidate RAG system update (retriever, prompt, or LLM) that degrades clinical correctness.
- **Observability**: Expose detailed tracing telemetry (latency, token count, cost, and citation matching) using enterprise MLOps components.
- **Continuous Improvement**: Provide a structured loop for comparing performance across experiments by cancer type, ICD-10 code, and demographic cohort.

## User Personas
- **Healthcare AI Engineer**: Restructures retrieval pipelines, optimizes embeddings, tests prompts, and views detailed trace latency/cost breakdowns.
- **Oncology Clinical Lead / Auditor**: Reviews audit logs of LLM answers compared to hospital guidelines to sign off on safety profiles.
- **Hospital CIO / Compliance Officer**: Monitors platform compliance dashboard, checking that all clinical guidelines data is secure and that models stay within cost budgets.
